URGENT MEDICAL TREATMENT FUNDRAISER

GIVE
TRISHAAN
A CHANCE

Help a Brave 3½-Year-Old Boy Fight PMD

Every child deserves the opportunity to smile, grow, and thrive. An urgent appeal to fund specialized neuro-developmental treatment for Trishaan and give him a chance to build a brighter future.

Trishaan
Campaign Target: ...

About Trishaan

Trishaan is diagnosed with Pelizaeus-Merzbacher Disease (PMD) caused by a PLP1 gene duplication. PMD is an ultra-rare genetic neurological disorder affecting 1 in a million children.

1 in 1M

Incidence Rate

3.5 Years

Critical Intervention

Treatment

Specialists recommend **Quantum Magnetic Resonance Therapy (QMRT/Cytotron)** at the Cytotron Centre. QMRT is a non-invasive therapy designed to stimulate nerve pathways to maximize his potential.

"While it is not a cure, it may help improve his quality of life."

Fundraising Goal

This specialized overseas treatment is completely uncovered by public provincial insurance in Canada. Every donation brings Trishaan closer to initiating pathway repair.

...

...

The Challenge: Understanding PMD

Following extensive diagnostic evaluations across Canada and India, advanced genetic testing confirmed that Trishaan has Pelizaeus-Merzbacher Disease (PMD) caused by a PLP1 gene duplication.

The Medical Analogy

"Imagine the brain as a city full of roads. Messages travel along these roads to control movement, balance, speech, and swallowing. Normally, these roads are covered with a protective coating called myelin that allows messages to travel quickly and clearly. In Trishaan's case, this coating did not develop properly. The roads are there, but the insulation is missing or very thin, causing messages to move slowly or become disrupted."

Because this essential biological insulation is compromised, basic physiological functions become massive hurdles. Trishaan experiences significant delays in motor development, poor balance, low muscle tone, and severe speech challenges, making independent sitting, standing, or walking impossible without aggressive clinical support.

Crucial Development Window

Why Immediate Timing Matters

Trishaan is currently at a critical evolutionary baseline. Early childhood represents the primary window for neuroplasticity—the young brain's unique capability to adapt, reorganize, and forge alternative neural connections.

Specialists emphasize that therapeutic interventions carry their highest impact during these early years when the central nervous system maintains its peak capacity for development. This window of opportunity is open right now, but it will close as he grows.

"This critical window to pursue the treatment is open today, but it won't remain open forever. As parents, we cannot let it pass and spend the rest of our lives wondering if we could have done more."

— Trishaan's Family

Watch Trishaan's Journey

Instagram Reels

Select Video to Play

The Cytotron

Why We Chose This Treatment

After years of research and consultations with specialists, we've decided to pursue Cytotron (QMRT) treatment for Trishaan. This is the same technology featured in movie Lucca's World, The film helped bring international attention to this treatment, giving hope to many families facing neurological conditions. While every child's journey is unique and outcomes cannot be guaranteed, we believe this offers Trishaan an opportunity worth pursuing.

Treatment Allocations (Per Cycle)

Expense Stream Cost Per Cycle
Cytotron Machine Therapy Direct medical session charges for specialized magnetic resonance sequences. ...
Advanced Neuro-Imaging High-resolution MRI neuro-mapping and tracking. ...
28-Day On-Site Logistics Local physical therapy, clinical observation, and travel buffers. ...
Total Requirements Per Single Cycle ...

*The total required goal is 3 cycles, which equates to ....*